SoftBank founder Masayoshi Son announces joint venture with Tempus in Japan to develop AI-powered personalized medical services, starting with oncology.
Tempus, founded by Eric Lefkofsky, aims to bring data-driven medical technology to Japan through SB Tempus, offering genomic testing, data aggregation, AI insights for personalized treatments.
Collection
[
|
...
]